John Lee
Overview
John Lee received $2M in total compensation, including $39K in salary, at Marathon Patent Group in 2022. John Lee also received an average of $775K at Decibel Therapeutics between 2021 and 2022, an average of $684K at PhaseBio Pharmaceuticals from 2017 to 2021, and an average of $1M at John Bean Technologies from 2009 to 2013.
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2013
- 2012
Decibel TherapeuticsExecutive Vice President, Chief Development Officer
Marathon Patent GroupCAO
Decibel TherapeuticsExecutive Vice President, Chief Development Officer
PhaseBio PharmaceuticalsChief Medical Officer
PhaseBio PharmaceuticalsChief Medical Officer
PhaseBio PharmaceuticalsChief Medical Officer
PhaseBio PharmaceuticalsChief Medical Officer
PhaseBio PharmaceuticalsChief Medical Officer
John Bean TechnologiesFormer Vice President and Division Manager AeroTech Division
John Bean TechnologiesFormer Vice President and Division Manager AeroTech Division
Source: SEC filings on April 28, 2023, June 23, 2023, April 22, 2022, April 24, 2020, April 5, 2019, April 2, 2014, March 28, 2013, and March 28, 2012.
Related executives
We found 35 more executives who work or worked at Marathon Patent Group, Decibel Therapeutics, PhaseBio Pharmaceuticals, andJohn Bean Technologies.
Hugh Gallagher
Marathon Patent Group
Chief Financial Officer
James Crawford
Marathon Patent Group
Chief Operating Officer
Fred Thiel
Marathon Patent Group
Chief Executive Officer
Laurence Reid
Decibel Therapeutics
Chief Executive Officer
Simeon Salzman
Marathon Patent Group
Chief Financial Officer
Adam Swick
Marathon Patent Group
Chief Growth Officer
Elisabeth Leiderman
Decibel Therapeutics
Chief Financial Officer
Anna Trask
Decibel Therapeutics
Executive Vice President, Chief People Officer
News
Marathon Patent Group CFO Hugh Gallagher receives $4.8M in 2022
June 23, 2023
Decibel Therapeutics CEO Laurence Reid's 2022 pay jumps 54% to $1.2M
April 28, 2023
PhaseBio Pharmaceuticals CEO Jonathan Mow's 2021 pay slips 13% to $1.5M
April 22, 2022
PhaseBio Pharmaceuticals CEO Jonathan Mow's 2019 pay jumps 102% to $1.2M
April 24, 2020
PhaseBio Pharmaceuticals CEO Jonathan Mow's 2018 pay jumps 37% to $596K
April 5, 2019